Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Srilatha Nalluri
Select BCL-2 Antagonism Restores Chemotherapy Sensitivity in High-Risk Neuroblastoma
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Impact of MYCN Status on Response of High-Risk Neuroblastoma to Neoadjuvant Chemotherapy
Journal of Pediatric Surgery
Medicine
Child Health
Surgery
Pediatrics
Perinatology
O-090 Foxo3 Is Activated in High-Risk Neuroblastoma and Contributes to Chemotherapy-Resistance and Angiogenesis
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk Neuroblastoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Maintenance DFMO Increases Survival in High Risk Neuroblastoma
Scientific Reports
Multidisciplinary
Treatment of Poor-Risk Neuroblastoma Patients With High-Dose Chemotherapy and Autologous Peripheral Stem Cell Rescue
Bone Marrow Transplantation
Transplantation
Hematology
BCL-2 Protein Frequency in Patients With High-Risk Diffuse Large B-Cell Lymphoma
Sao Paulo Medical Journal
Medicine
High-Dose Chemotherapy in High-Risk Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Telomere Maintenance Is Pivotal for High-Risk Neuroblastoma
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Gonadal Failure Is Common in Long-Term Survivors of Childhood High-Risk Neuroblastoma Treated With High-Dose Chemotherapy and Autologous Stem Cell Rescue
Frontiers in Endocrinology
Endocrinology
Metabolism
Diabetes